Disease / condition

Chronic Heart Failure clinical trials

Free access to 235 studies·10+ countries·Updated daily32 recruiting
235
Total trials
10+
Countries
10+
Sponsors
32
Recruiting
By phase
N/A147
Phase 226
Phase 320
Not Applicable14
Phase 113
By status
Completed113
Unknown35
Recruiting32
Not yet recruit...26
Terminated13
Top countries
China30
United States of America27
Japan26
France14
United Kingdom13
Top sponsors
Medtronic Cardiac ...7
Novartis Pharmaceu...7
University of Leed...7
Zensun Sci. & Tech...6
Federico II Univer...6
Recent trials
Latest clinical trials for Chronic Heart Failure
NCT06393595Recruitment ...
Prediction of Outcomes in Patients With Chronic Heart Failure Based on Tissue Raman Spectroscopy
Samara State Medical Universit...Russian Federation
NCT06360315Recruitment ...
Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
University Hospital, Montpelli...France
NCT06299826·Phase 2Not yet recr...
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
AstraZeneca
NCT06266988·Phase 1Not yet recr...
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
Viatris Inc.
NCT06130319Recruiting
Correlation of Disease Management and Quality of Life in Patients With Chronic Heart Failure and Their Family Caregivers
Sun Yat-Sen Memorial Hospital ...China
NCT06117722Not yet recr...
TorasEmide Induced Effect on Quality of Life and Clinical parameterS in paTients With chronIc heArt Failure Receiving Eplerenone.
Elpen Pharmaceutical Co. Inc.
NCT06036615Recruiting
The Effect of Exercise Training and Detraining on Frailty and Fall Risk in Patients With Chronic Heart Failure
Aristotle University Of Thessa...Greece
NCT06017609·Phase 2Recruiting
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
Akros Pharma Inc.United States of America
NCT06019169Not yet recr...
Impact of YOGA on the Quality of Life and Well-being of Heart Failure Patients
Assistance Publique - Hôpitaux...France
NCT05848206Completed
Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.
Novartis PharmaceuticalsUnited States of America
NCT05876533Recruiting
R&D Study to Evaluate Cordio's Usability and to Collect Patient Speech Utterances
Cordio MedicalIsrael,United States of America
NCT05966415·Phase 2Recruiting
Endocalyx for Heart Failure
Academisch Medisch Centrum - U...Netherlands
NCT05802849·Phase 4Not yet recr...
Acetazolamide Per os for Decompensation of Heart Failure
Samara State Medical Universit...
NCT05659264·Phase 1Recruiting
A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure
ModernaTX, Inc.Poland,United Kingdom
NCT05666518Recruiting
A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
BayerJapan
jRCT1030220476Not yet recr...
Untitled Trial
Japanese Nursing Association: ...
NCT05613140Completed
Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure
Novartis PharmaceuticalsUnited States of America
NCT05862350Not yet recr...
Effects of Lavender Essential Oil in Patients With Chronic Heart Failure
First Affiliated Hospital Xi'a...
NCT05532046·Phase 1Recruiting
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
BayerAustria,Bulgaria,Czech,Denmark,Germany,Hungary,Israel,Italy,Spain,United Kingdom,United States of Am
UMIN000047055Completed
Patient Survey on Burdens, Perceptions, Self-care and Treatment Support of Living with Heart Failure in Japan
Nippon Boehringer Ingelheim Co...Japan
About this record

Access comprehensive clinical trial information for Chronic Heart Failure through Pure Global AI's free database. This collection includes 235 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 32 trials are actively recruiting participants.

Research for Chronic Heart Failure is being conducted in China, United States of America, Japan and 7+ other countries. Leading sponsors include Medtronic Cardiac Rhythm and Heart Failure and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 235 clinical trials studying Chronic Heart Failure, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Medtronic Cardiac Rhythm and Heart Failure, Novartis Pharmaceuticals, University of Leeds, among others.